These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30052684)

  • 21. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
    Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
    Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children.
    Jin Y; Xie Z; Lu G; Yang S; Shen K
    Virol J; 2010 May; 7():92. PubMed ID: 20459737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
    Lupey-Green LN; Moquin SA; Martin KA; McDevitt SM; Hulse M; Caruso LB; Pomerantz RT; Miranda JL; Tempera I
    Virology; 2017 Jul; 507():220-230. PubMed ID: 28456021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.
    Yu X; McCarthy PJ; Wang Z; Gorlen DA; Mertz JE
    J Virol; 2012 Aug; 86(15):8086-96. PubMed ID: 22623769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characterization of BZLF1 gene and its promoter Zp of EBV strains in children with EBV-associated diseases in recent 5 years in Beijing area].
    Liu YL; Ai UH; Yan J; Guan XL; Liu CY; Xie ZD
    Bing Du Xue Bao; 2014 Jan; 30(1):6-12. PubMed ID: 24772891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.
    Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC
    J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
    Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
    J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases.
    Correia S; Bridges R; Wegner F; Venturini C; Palser A; Middeldorp JM; Cohen JI; Lorenzetti MA; Bassano I; White RE; Kellam P; Breuer J; Farrell PJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30111570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.
    Wille CK; Nawandar DM; Panfil AR; Ko MM; Hagemeier SR; Kenney SC
    J Virol; 2013 Jan; 87(2):935-50. PubMed ID: 23135711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters.
    Verma D; Church TM; Swaminathan S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13044-13055. PubMed ID: 32434920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
    Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
    J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus BZLF1 gene promoter variants in pediatric patients with acute infectious mononucleosis: its comparison with pediatric lymphomas.
    Lorenzetti MA; Gutiérrez MI; Altcheh J; Moscatelli G; Moroni S; Chabay PA; Preciado MV
    J Med Virol; 2009 Nov; 81(11):1912-7. PubMed ID: 19774688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
    Wang M; Wu W; Zhang Y; Yao G; Gu B
    Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.
    Feng WH; Kraus RJ; Dickerson SJ; Lim HJ; Jones RJ; Yu X; Mertz JE; Kenney SC
    J Virol; 2007 Sep; 81(18):10113-22. PubMed ID: 17626078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression.
    Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S
    J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching of EBV cycles between latent and lytic states.
    Murata T; Tsurumi T
    Rev Med Virol; 2014 May; 24(3):142-53. PubMed ID: 24339346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.